Advanced Care Growth · Investment Case · Prepared for COO review

They already win in the chair. They lose at the phone.

New Horizons, Peak, and MainStreet generate demand and close it — 80–100% show rates, 33–94% close rates. What's missing is a person dedicated to turning leads into consults. Fund a dedicated setter, scale paid media, and add clinical capacity, and the funnel we already have converts.

12-mo incremental revenue
above status-quo run-rate
Investment (12 mo)
same across every scenario
Blended incremental ROAS
return per $1 invested
24-mo incremental revenue
as capacity holds

Showing the Base scenario — a blend of SGA's internal 25% booking target and a dedicated-setter benchmark. Investment is identical in all three scenarios; only the return changes.

The portfolio

Three practices, one bottleneck

Each already has the hard parts — demand and clinical skill. Each is capped by the same missing role.

New Horizons

Implant / full-arch center

  • ~90 leads/mo at $28–45 CPL — plenty of demand
  • Once presented: 84–100% show, ~33% close
  • Sarah splits setter + treatment coordinator + front desk across locations — lead speed suffers
  • Strong months prove it: when Sarah is dedicated, bookings jump
Peak Family Dental

3 AZ locations

  • Flagstaff · Cottonwood · Sedona
  • Elite conversion: 90% show, 94% close in FY25
  • Office manager is TC and works leads — and isn't incentivized on performance
  • Notes say it plainly: "no outbound calls from the system"
MainStreet

Implant program — capital case

  • Dr. Jimenez places implants; practice historically referred every case out
  • 39 implant referrals last year to one now-closed surgeon; 267+ since 2023
  • 30–40 VA community-care cases already submitted
  • Needs an on-site CBCT to bring the work in-house
Where they are today

Elite where it's hard. Broken where it's cheap to fix.

Every funnel stage below, measured against SGA's own targets. The practices blow past target on show and close — and collapse at contact and booking, the one thing a dedicated setter fixes.

Funnel performance vs. target

New Horizons and Peak, trailing. Green = beating target · Red = missing it.

New HorizonsPeakSGA target
The leads are cheap and plentiful. The chairs convert. The phone is the leak.

At 80–100% show and 33–94% close, contact and booking are the only stages under target. That's not a demand problem or a clinical problem — it's a staffing problem with a known fix.

~5–13%
of leads contacted (target 60%)
~3–10%
of leads booked (target 25%)
80–100%
show rate ✓ beats target
33–94%
close rate ✓ beats target

Historical monthly revenue — an unmanaged pipeline

Revenue arrives in lumps because leads are worked in bursts, not as a system. FY25: New Horizons $158k · Peak $281k.

New HorizonsPeak
Where they've been

Proven economics, inconsistent throughput

FY25 revROASClose
New Horizons$158k2.9x33%
Peak$281k4.1x94%

Peak closed 94% of everything presented in FY25 — and still only got ~20 consults booked from 682 leads. The ceiling isn't closing. It's getting patients to the table.

The opportunity

A dedicated setter, and a pipeline we actually manage

Bring on a third-party setter (Briteline) dedicated to working leads the moment they arrive. Treatment coordinators stop chasing and start closing. The funnel becomes a managed pipeline instead of a to-do list.

The mechanism

Speed to lead

A dedicated setter calls leads in minutes, not days — moving booking rate from ~10% toward 27% (blend of the 25% internal target and a dedicated-setter benchmark).

The unlock

Fill existing capacity

Show and close stay at proven levels. Cases rise from ~1–2/mo toward the practice's own stated ceiling of ~8 arches/mo — the chairs are already there.

The discipline

Honest math

Modeled at trailing realized case value (~$16–17k), not the $40,500 full-arch case. AoF economics are upside, not the base. Kim Middleton (financing + coaching) is a separate lever.

Today ~1–2 cases a month reach the table. The setter's job is to make it 7–8 — filling capacity the practice already has.
The revenue opportunity

Same investment. Here's the range of return.

Conservative, base, and aggressive differ only in how fully throughput and case-mix land. Investment is identical. Toggle the scenario in the top-right — the whole case updates.

12-month incremental revenue by practice

Active scenario in full color; the other two shown faint for context.

Practice12-mo incr. revPayback24-mo incr. rev

Baseline = each practice's trailing status-quo run-rate. Incremental = modeled revenue above that baseline. Gross margin held at 40% (NH/Peak) and 45% (MainStreet implants), per the implant performance files.

The return

Payback inside 7 months at New Horizons and Peak

Cumulative incremental gross margin overtakes cumulative investment fast, because the setter fills capacity the practices already staff. MainStreet is a capital case — slower, but the CBCT itself pays back in under three months of implant margin.

Portfolio: cumulative incremental gross margin vs. cumulative investment

24 months. Where gold crosses navy, the program's margin has covered its investment.

Cumulative incremental gross marginCumulative investment
New Horizons payback
Peak payback
MainStreet payback
Blended incremental ROAS
40–45%
Gross margin held
24-mo incremental revenue
The investment

Where the $712k goes

Roughly half is media — the fuel. The setter is the thesis. MainStreet's CBCT is the one capital item. Kim Middleton (sales coaching + financing) sits on top as optional upside, not in the base.

12-month investment by category — all three practices

Total ≈ $712k. Media scales from $9k/mo toward $15k; the setter is a flat, high-leverage line.

Avenues of scale

Media: $9k → $15k → $21k

Base ramps media to $15k/mo. Every practice has room to push to $21k+ as capacity fills — the fastest lever to more leads once the setter is converting them.

Optional upside — not in base

Kim Middleton · $2k/practice

Sales coaching and financing setup. Lifts close rate and lets bigger (full-arch) cases through. Flip it on in the model to see the effect; the base case stands without it.

MainStreet — the capital case

Recapturing implants we already send away

This one isn't about a setter — it's a CBCT and an implant ramp. The demand already exists; the practice just exports it.

The recapture

  • 39 implant-eligible referrals last year to one oral surgeon — who has now retired/sold
  • 267+ referred out since 2023
  • 30–40 VA community-care cases already submitted
  • The perio referral office closed too — that volume is unclaimed

The capital

  • On-site CBCT — $38k (open-box unit already sourced)
  • Surgical + restorative staffing and training
  • Conservative ramp to ~10 implants/mo at $4,500 each
  • Locator-fixed full-arch as upside from month 7

The return

  • Program payback ~month 13 (carries the CBCT)
  • The CBCT hardware pays back in <3 months of implant gross margin
  • 45% gross margin on implants
  • Every case kept in-house is margin that used to leave the building
The ask

Approve across the three practices over 12 months.

A dedicated setter at New Horizons and Peak, paid media scaled to $9k+ at each, and MainStreet's on-site CBCT. Base case: in incremental revenue at blended ROAS, with New Horizons and Peak paying back inside 7 months.

  1. Contract the dedicated setter (Briteline) at New Horizons and Peak — non-optional; it's the whole thesis.
  2. Scale paid media to $9k/mo minimum at each practice, with a path to $15–21k as capacity fills.
  3. Fund MainStreet's CBCT and implant ramp to recapture referred-out cases.
  4. Hold Kim Middleton (coaching + financing) as a fast-follow lever once setters are live.
  5. Manage it as a pipeline: weekly lead-to-consult reporting, treatment coordinators freed to close.
Sources: SGA New Horizons Implant Performance & Peak Implant Analysis (Performance Funnel, Sale Waterfall); New Horizons & Peak Monthly Reports; Briteline rate card; Dr. Jimenez call notes & referral-recapture data. Gross margin per implant performance files (40% NH/Peak, 45% MainStreet implants). Figures are modeled and tie to the accompanying Excel model. Net margin excluded by design. SGA Dental Partners — confidential.